Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CREB1 promotes expression of immune checkpoint HLA-E leading to immune escape in multiple myeloma

Leukemia(2024)10.1038/s41375-024-02303-wSource: DataRank Database

CREB1 promotes expression of immune checkpoint HLA-E leading to immune escape in multiple myeloma is a research paper published in Leukemia (2024). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.25)OA: hybridTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Allen J. Robinette,Laila Huric,Jamie Schuetz,Kameron Dona,Don Benson

Live enrichment

PubMed:38902472 PMC:PMC11286514 OpenAlex:https://openalex.org/W4399856282

NCI NIH HHS

Grant: R01 CA270251

NCI NIH HHS

Grant: K08 CA263476

NCI NIH HHS

Grant: P30 CA016058

National Institutes of Health

Grant: 1K08CA263476-01A1

Investigating CD56 signaling in multiple myeloma growth and immune escape

National Institutes of Health

Grant: 5R01CA270251-03

A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL

FWCI

2.25

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1038/s41375-024-02303-w

publisherhttps://doi.org/10.1038/s41375-024-02303-w

publisherhttps://www.nature.com/articles/s41375-024-02303-w.pdf

publisherhttps://www.nature.com/articles/s41375-024-02303-w

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38902472

Fields of Study

Immune Cell Function and InteractionMultiple Myeloma Research and TreatmentsImmunotherapy and Immune Responses0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HLA-E AntigensHumansInterferon-gammaKiller Cells, NaturalMultiple MyelomaHistocompatibility Antigens Class IGene Expression Regulation, NeoplasticCyclic AMP Response Element-Binding ProteinTumor EscapeCell Line, TumorTumor Microenvironment

Keywords

Immune systemBiologyImmunologyMajor histocompatibility complexCancer researchHistocompatibility Antigens Class IArticleKiller Cells, NaturalGene Expression Regulation, NeoplasticInterferon-gammaCell Line, TumorTumor MicroenvironmentHumansTumor EscapeMultiple MyelomaCyclic AMP Response Element-Binding ProteinHLA-E Antigens

Sustainable Development Goals

SDG 0: Good health and well-being